BSE filing, NSE: CHOICEIN. Summary written from the filing by ALFA Finder's alert engine.
Choice International Ltd: key numbers
- Share price
- ₹730.20
- Market cap
- ₹16,267 Cr
- Revenue (annual)
- ₹1,119 Cr
- Net profit (annual)
- ₹217.7 Cr
- P/E (TTM)
- 66.9×Sector 19.7×
- Promoter holding
- 53.65%+0.00% QoQ
- FII holding
- 9.97%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Choice International Ltd
All →Choice International Board Meeting Date
Choice International will hold a board meeting on 2 November 2026 to approve unaudited results for the quarter and half year ended 30 September 2026. The board will also consider recommending a bonus share issue, subject to shareholder approval.
Choice International Capital Structure Change
Choice International's material subsidiary CEBPL allotted 42.25 lakh CCPS to NH Investment & Securities for about ₹900 Crore. The allotment does not change control of CEBPL.
- Value
- ₹900.0 Cr
Choice International Annual General Meeting
Choice International Limited held its 33rd Annual General Meeting on September 26, 2026, to discuss and vote on various ordinary and special business resolutions.
Choice International Annual General Meeting
Choice International Ltd scheduled its 33rd Annual General Meeting for September 26, 2026, announcing book closure dates from September 20 to September 26.
Choice International Share Pledge
Promoter Arun Kumar Poddar released encumbrance on 6,00,000 shares of Choice International Limited. The filing discloses the reduction in pledged promoter shares.
Choice International Share Pledge
Choice International promoter Arun Kumar Poddar released a pledge on 600,000 shares, valued at ₹46.11 Crore. This transaction reduces encumbrances on promoter equity.
- Value
- ₹46.11 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.